Literature DB >> 27481575

Image-guided biopsy in primary lung cancer: Why, when and how.

C de Margerie-Mellon1, C de Bazelaire2, E de Kerviler2.   

Abstract

Initial histopathological analysis of a pulmonary lesion is mandatory whenever a lung cancer is suspected in order to determine the optimal diagnostic strategy. Adequate material must be obtained for a definite histological diagnosis (preferable to a cytological one) and in some cases (mainly in adenocarcinoma) molecular analysis. The two main methods to obtain adequate biopsy samples are flexible bronchoscopy and computed tomography (CT)-guided lung biopsy. Flexible bronchoscopy is a valuable method for proximal tumors. On the other hand, CT-guided lung biopsy is more accurate for peripheral tumors. CT-guided lung biopsy is a reliable procedure that conveys a 90% sensitivity for the diagnosis of lung cancer. When performed in a secured environment after contraindications evaluation, its severe complications rate is low, mainly consisting of pneumothorax requiring chest tube placement and hemoptysis.
Copyright © 2016 Editions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Computed tomography; Image-guided biopsy; Lung biopsy; Lung cancer

Mesh:

Year:  2016        PMID: 27481575     DOI: 10.1016/j.diii.2016.06.016

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN: 2211-5684            Impact factor:   4.026


  8 in total

1.  Automated approach for segmenting gross tumor volumes for lung cancer stereotactic body radiation therapy using CT-based dense V-networks.

Authors:  Yunhao Cui; Hidetaka Arimura; Risa Nakano; Tadamasa Yoshitake; Yoshiyuki Shioyama; Hidetake Yabuuchi
Journal:  J Radiat Res       Date:  2021-03-10       Impact factor: 2.724

2.  Discriminating lung adenocarcinoma from lung squamous cell carcinoma using respiration-induced tumor shape changes.

Authors:  Yi Lao; John David; Amin Mirhadi; Natasha Lepore; Howard Sandler; Yalin Wang; Richard Tuli; Wensha Yang
Journal:  Phys Med Biol       Date:  2018-11-07       Impact factor: 3.609

3.  Management of superior vena cava syndrome in critically ill cancer patients.

Authors:  Sarah Morin; Adeline Grateau; Danielle Reuter; Eric de Kerviler; Constance de Margerie-Mellon; Cédric de Bazelaire; Lara Zafrani; Benoit Schlemmer; Elie Azoulay; Emmanuel Canet
Journal:  Support Care Cancer       Date:  2017-08-24       Impact factor: 3.603

Review 4.  Lung, Pleural, and Mediastinal Biopsies: From Preprocedural Assessment to Technique and Management of Complications.

Authors:  Natasha Larocque; Olga R Brook
Journal:  Semin Intervent Radiol       Date:  2022-08-31       Impact factor: 1.780

5.  Machine learning based on clinico-biological features integrated 18F-FDG PET/CT radiomics for distinguishing squamous cell carcinoma from adenocarcinoma of lung.

Authors:  Caiyue Ren; Jianping Zhang; Ming Qi; Jiangang Zhang; Yingjian Zhang; Shaoli Song; Yun Sun; Jingyi Cheng
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-10-15       Impact factor: 9.236

6.  Computed Tomography-guided Transthoracic Core Needle Biopsy of Lung Masses: Technique, Complications and Diagnostic Yield Rate.

Authors:  Cennet Şahin; Onur Yılmaz; Burçin Ağrıdağ Üçpınar; Ramazan Uçak; Uğur Temel; Muzaffer Başak; Aylin Hasanefendioğlu Bayrak
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2020-03-25

7.  Proteomic Approach for Searching for Universal, Tissue-Specific, and Line-Specific Markers of Extracellular Vesicles in Lung and Colorectal Adenocarcinoma Cell Lines.

Authors:  Svetlana Novikova; Natalia Shushkova; Tatiana Farafonova; Olga Tikhonova; Roman Kamyshinsky; Victor Zgoda
Journal:  Int J Mol Sci       Date:  2020-09-09       Impact factor: 5.923

8.  C-Arm Cone-Beam CT Virtual Navigation versus Conventional CT Guidance in the Transthoracic Lung Biopsy: A Case-Control Study.

Authors:  Lian Yang; Yue Wang; Lin Li; Dehan Liu; Xin Wu; Wei Zhang; Feng Pan; Huimin Liang; Chuansheng Zheng
Journal:  Diagnostics (Basel)       Date:  2022-01-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.